关注
Thorvardur Halfdanarson
Thorvardur Halfdanarson
Professor of Oncology
在 mayo.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ...
The Lancet 395 (10241), 1907-1918, 2020
18602020
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
TR Halfdanarson, KG Rabe, J Rubin, GM Petersen
Annals of oncology 19 (10), 1727-1733, 2008
9862008
Treatment-related adverse events of PD-1 and PD-L1 inhibitors in clinical trials: a systematic review and meta-analysis
Y Wang, S Zhou, F Yang, X Qi, X Wang, X Guan, C Shen, N Duma, ...
JAMA oncology 5 (7), 1008-1019, 2019
6822019
Hematologic manifestations of celiac disease
TR Halfdanarson, MR Litzow, JA Murray
Blood 109 (2), 412-421, 2007
5202007
Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors
TR Halfdanarson, J Rubin, MB Farnell, CS Grant, GM Petersen
Endocrine-related cancer 15 (2), 409, 2008
4792008
Neuroendocrine tumors, version 1.2015
MH Kulke, MH Shah, AB Benson, E Bergsland, JD Berlin, LS Blaszkowsky, ...
Journal of the National Comprehensive Cancer Network 13 (1), 78-108, 2015
4092015
Factors predicting response, perioperative outcomes, and survival following total neoadjuvant therapy for borderline/locally advanced pancreatic cancer
MJ Truty, ML Kendrick, DM Nagorney, RL Smoot, SP Cleary, RP Graham, ...
Annals of surgery 273 (2), 341-349, 2021
3562021
Neuroendocrine and adrenal tumors, version 2.2021, NCCN clinical practice guidelines in oncology
MH Shah, WS Goldner, AB Benson, E Bergsland, LS Blaszkowsky, ...
Journal of the National Comprehensive Cancer Network 19 (7), 839-868, 2021
3472021
Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial
JL Welsh, BA Wagner, TJ Van’t Erve, PS Zehr, DJ Berg, TR Halfdanarson, ...
Cancer chemotherapy and pharmacology 71, 765-775, 2013
3412013
NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2.2018
MH Shah, WS Goldner, TR Halfdanarson, E Bergsland, JD Berlin, ...
Journal of the National Comprehensive Cancer Network 16 (6), 693-702, 2018
3372018
Hematological manifestations of copper deficiency: a retrospective review
TR Halfdanarson, N Kumar, CY Li, RL Phyliky, WJ Hogan
European journal of haematology 80 (6), 523-531, 2008
3172008
The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors
JR Strosberg, TR Halfdanarson, AM Bellizzi, JA Chan, JS Dillon, ...
Pancreas 46 (6), 707-714, 2017
3002017
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ...
Annals of oncology 32 (6), 787-800, 2021
2972021
The North American Neuroendocrine Tumor Society consensus paper on the surgical management of pancreatic neuroendocrine tumors
JR Howe, NB Merchant, C Conrad, XM Keutgen, J Hallet, JA Drebin, ...
Pancreas 49 (1), 1-33, 2020
2912020
A single-institution experience with 491 cases of small bowel adenocarcinoma
TR Halfdanarson, RR McWilliams, JH Donohue, JF Quevedo
The American journal of surgery 199 (6), 797-803, 2010
2562010
Radiofrequency ablation versus stereotactic body radiotherapy for localized hepatocellular carcinoma in nonsurgically managed patients: analysis of the national cancer database
DJ Rajyaguru, AJ Borgert, AL Smith, RM Thomes, PD Conway, ...
Journal of Clinical Oncology 36 (6), 600-608, 2018
1892018
Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19
MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ...
JAMA oncology 7 (8), 1167-1175, 2021
1762021
Colorectal cancer-review
S Haraldsdottir, HM Einarsdottir, A Smaradottir, A Gunnlaugsson, ...
Laeknabladid 100 (2), 75-82, 2014
1742014
Oncologic emergencies: diagnosis and treatment
TR Halfdanarson, WJ Hogan, TJ Moynihan
Mayo Clinic Proceedings 81 (6), 835-848, 2006
1542006
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) cohort study
DR Rivera, S Peters, OA Panagiotou, DP Shah, NM Kuderer, CY Hsu, ...
Cancer discovery 10 (10), 1514-1527, 2020
1412020
系统目前无法执行此操作,请稍后再试。
文章 1–20